Use of H19 regulatory sequences for targeted gene therapy in cancer
暂无分享,去创建一个
Morris Laster | Abraham Hochberg | A. Hochberg | N. de Groot | H. Giladi | I. Matouk | S. Ayesh | M. Laster | I. Ariel | Suhail Ayesh | Tamar Schneider | Ilana Ariel | Nathan de Groot | T. Birman | T. Schneider | P. Ohana | Hilla Giladi | Patricia Ohana | Osaat Bibi | Imad Matouk | Carol Levy | Tatiana Birman | O. Bibi | C. Levy
[1] R. Palmiter,et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene , 1987, Cell.
[2] M. Hashida,et al. Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice , 1999, Gene Therapy.
[3] Michael Weber,et al. H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation , 2000, Oncogene.
[4] A. Hochberg,et al. The expression of the H19 gene and its function in human bladder carcinoma cell lines , 1999, FEBS letters.
[5] H. Yamasaki,et al. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. , 2000, Cancer research.
[6] R. Vile,et al. In vitro and in vivo targeting of gene expression to melanoma cells. , 1993, Cancer research.
[7] V. Erdmann,et al. The product of the imprinted H19 gene is an oncofetal RNA. , 1997, Molecular pathology : MP.
[8] A. Hochberg,et al. The effect of retinoic acid on the activation of the human H19 promoter by a 3′ downstream region , 1998, FEBS letters.
[9] G. A. Hofmann,et al. Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] I. Maxwell,et al. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide. , 1986, Cancer research.
[11] M. Ishiura,et al. Complete nucleotide sequence and characterization of the 5'-flanking region of mammalian elongation factor 2 gene. , 1988, The Journal of biological chemistry.
[12] A. Hochberg,et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma , 2000, Molecular pathology : MP.
[13] A. Hochberg,et al. Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone. , 1999, Cancer research.
[14] A. Hochberg,et al. The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. , 1998, Carcinogenesis.
[15] G. Nabel,et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Briand,et al. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. , 1975, Cancer research.
[17] A. Hochberg,et al. Developmentally imprinted genes as markers for bladder tumor progression. , 1996, The Journal of urology.
[18] A. Hochberg,et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.
[19] Morris Laster,et al. Characterization of human and mouse H19 regulatory sequences , 2000, Molecular Biology Reports.
[20] D. Liggitt,et al. Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.